Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 9.42
0.00 (0.00%)
Mar 30, 2026, 3:06 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 6.23 billion as of March 27, 2026. Its market cap has decreased by -10.54% in one year.
Market Cap
6.23B
Enterprise Value
8.73B
Revenue
1.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.42
Market Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has increased from 4.81B to 6.23B, an increase of 29.53%. That is a compound annual growth rate of 1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.23B | 3.52% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 7.09B |
| Wuhan Keqian Biology Co.,Ltd | 6.82B |
| Jiangsu Aidea Pharmaceutical Group | 6.74B |
| Shenzhen Weiguang Biological Products | 6.24B |
| GemPharmatech | 6.00B |
| Lifecome Biochemistry | 5.92B |
| R&G PharmaStudies | 5.91B |
| Beijing Konruns Pharmaceutical | 5.85B |